Compare Stocks

Date Range: 

 United CannabisWebSafetyFeedbackMineworx TechnologiesInstem
SymbolOTCMKTS:CNABOTCMKTS:WBSILON:FDBKCVE:MWXLON:INS
Price Information
Current Price$0.01$2.00GBX 1.28C$0.08GBX 685
52 Week RangeN/AN/AN/AN/AN/A
MarketRank™
Overall Score0.40.50.50.60.5
Analysis Score0.00.00.00.00.0
Community Score2.12.52.53.21.8
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.00.00.00.6
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$1.22 millionN/A£13.60 millionC$27.99 million£149.20 million
BetaN/AN/AN/AN/AN/A
Average Volume730,43310,6022,369,914530,65435,928
Sales & Book Value
Annual RevenueN/AN/A£345,983.00N/A£28.22 million
Price / SalesN/AN/A39.32N/A5.29
CashflowN/AN/AGBX 0.41 per shareC$0.01 per shareGBX 132.40 per share
Price / CashN/AN/A3.139.295.17
Book ValueN/AN/AGBX 0.60 per shareC$0.03 per shareGBX 164.70 per share
Price / BookN/AN/A0.02N/A0.04
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AN/AGBX (0.20)C($0.02)GBX 11.60
Trailing P/E Ratio0.000.00N/AN/A59.05
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A12.39%6.27%
Current RatioN/AN/A11.12%2.94%2.44%
Quick RatioN/AN/A11.12%2.24%2.43%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees65N/A12N/A268
Shares Outstanding93.73 millionN/A1.07 billion322.77 million21.78 million
Next Earnings DateN/AN/AN/A5/27/2021 (Estimated)5/31/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
inStem Recruitment 2021: Project AssociateinStem Recruitment 2021: Project Associate
sakshieducation.com - May 5 at 11:26 AM
Is Instems (LON:INS) Share Price Gain Of 193% Well Earned?Is Instem's (LON:INS) Share Price Gain Of 193% Well Earned?
finance.yahoo.com - May 3 at 7:34 AM
Instem plc - Exercise of Options, Issue of Equity and TVRInstem plc - Exercise of Options, Issue of Equity and TVR
proactiveinvestors.co.uk - April 20 at 6:48 PM
Instem highlight resilience of business in difficult climate for many after revenues increased 10%Instem highlight 'resilience of business in difficult climate for many' after revenues increased 10%
proactiveinvestors.co.uk - April 13 at 8:37 AM
Instem swings to profit as clients buy software for Covid-19 projectsInstem swings to profit as clients buy software for Covid-19 projects
lse.co.uk - April 12 at 2:11 PM
Instem Share News (INS)Instem Share News (INS)
lse.co.uk - April 12 at 2:11 PM
Instem swings to profit as revenue boosted by new, existing business winsInstem swings to profit as revenue boosted by new, existing business wins
stockmarketwire.com - April 12 at 9:10 AM
Instem earnings increase, says well placed for continued growthInstem earnings increase, says well placed for continued growth
proactiveinvestors.co.uk - April 12 at 9:10 AM
Instem has good visibility for the current yearInstem has good visibility for the current year
proactiveinvestors.co.uk - April 12 at 9:10 AM
Instem plc : Completion of Acquisition of d-wiseInstem plc : Completion of Acquisition of d-wise
markets.businessinsider.com - April 7 at 6:31 AM
Tracsis, Instem and Quixant scheduled to report.Tracsis, Instem and Quixant scheduled to report.
proactiveinvestors.co.uk - April 6 at 7:35 AM
A nano torch for cellsA nano torch for cells
thehindubusinessline.com - March 28 at 6:57 PM
Instem buys D-Wise to fills important gap in coverage across whole of life sciences R&DInstem buys D-Wise to 'fills important gap in coverage across whole of life sciences R&D'
proactiveinvestors.co.uk - March 23 at 8:11 AM
Technology business makes £22m American acquisitionTechnology business makes £22m American acquisition
thebusinessdesk.com - March 22 at 7:07 AM
Instem plc - Acquisition of d-wise and Investor PresentationInstem plc - Acquisition of d-wise and Investor Presentation
proactiveinvestors.co.uk - March 22 at 7:07 AM
Instem exchanges contracts on clinical trial firm buyInstem exchanges contracts on clinical trial firm buy
insidermedia.com - March 22 at 7:07 AM
Instem snaps up US peer D-Wise for maximum US$31mlnInstem snaps up US peer D-Wise for maximum US$31mln
proactiveinvestors.co.uk - March 22 at 7:07 AM
Instem Acquires d-wiseInstem Acquires d-wise
finsmes.com - March 22 at 7:07 AM
Instem Acquires Market Leader d-wise to Further Accelerate Life Science DevelopmentInstem Acquires Market Leader d-wise to Further Accelerate Life Science Development
finance.yahoo.com - March 22 at 7:07 AM
Instem To Acquire D-Wise Technologies In Up To $31 Mln Cash, Stock DealInstem To Acquire D-Wise Technologies In Up To $31 Mln Cash, Stock Deal
markets.businessinsider.com - March 22 at 7:07 AM
Sensor developed for identification of new cancer therapeutic drugsSensor developed for identification of new cancer therapeutic drugs
dailypioneer.com - March 20 at 7:46 PM
Researchers develop molecular sensor that can identify cancer drugsResearchers develop molecular sensor that can identify cancer drugs
msn.com - March 16 at 9:19 AM
Scientists at inStem, Bengaluru, develop molecular sensor that will help identify new cancer drugsScientists at inStem, Bengaluru, develop molecular sensor that will help identify new cancer drugs
uniindia.com - March 16 at 9:19 AM
InStem, Curie Institute scientists develop molecular sensor to detect cancer drugsInStem, Curie Institute scientists develop molecular sensor to detect cancer drugs
pharmabiz.com - March 12 at 2:00 AM
Is Instem plc (LON:INS) Worth UK£5.3 Based On Its Intrinsic Value?Is Instem plc (LON:INS) Worth UK£5.3 Based On Its Intrinsic Value?
finance.yahoo.com - March 3 at 8:54 AM
DateCompanyBrokerageAction
(Data available from 5/6/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.